PlainPharmaWatch

CMS Open Payments · Program Year 2024

ADMA BioManufacturing LLC

ADMA BioManufacturing LLC reported $465,066.11 across General Payments, Research, and Ownership to 1,058 physicians and teaching hospitals across 1,111 transactions.

$465.1K Above-median payer
All-tracks total
1,111 Above-median volume
Transactions
1,058 Above-median reach
Recipients
+$47.2K
General Payments vs PY2023

ADMA BioManufacturing LLC reported $465,066.11 across all CMS Open Payments tracks (General + Research + Ownership) to 1,058 physicians and teaching hospitals in Program Year 2024 - ranking #781 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $167,654.40, averaging $439.57 per recipient.

How ADMA BioManufacturing LLC's $465.1K all-tracks total breaks down

ADMA BioManufacturing LLC's payment reach score

Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.

Overall reach score

F

28/100

Total payments

F

14/100

Transaction volume

F

18/100

Physician reach

F

18/100

Payment type diversity

D

63/100

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

CMS Sunshine Act warrant

Manufacturer adma-biomanufacturing-llc ADMA BioManufacturing LLC

$465.1K · #781/1,925 · 0.0% industry · PY2024

  • TOT $465.1K
  • RANK #781
  • SHARE 0.0%
  • TXN 1,111
  • RCP 1,058
  • CAT 5
  • GEN $167.7K
  • ΔGEN +$47.2K
  • TOP1 15.7%
  • PY 2024

Nearest volume peer: Getinge USA Sales, LLC ($462.9K)

Sixth Street Solutions, LLC$473.8KiCAD, Inc$467.3KADMA BioManufacturing LLC (t…$465.1KGetinge USA Sales, LLC$462.9KUoc USA Inc$460.8K
All-tracks payment totals near ADMA BioManufacturing LLC (CMS Open Payments PY2024)

ADMA BioManufacturing LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

ADMA BioManufacturing LLC's CMS-reported General Payments increased by $47.2K (+39.2%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: ADMA BIOMANUFACTURING LLCPY2023: ADMA BIOMANUFACTURING LLCPY2024: ADMA BioManufacturing LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$120.5KPY2024$167.7K
PY2023
$120,482.51
PY2024
$167,654.40

What the Data Shows for ADMA BioManufacturing LLC

Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For ADMA BioManufacturing LLC, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.

The 5-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Honoraria" at $97.2K, accounting for 58.0% of this company's General Payments and 32 transactions.

General Payment Breakdown by Type

"Honoraria" leads ADMA BioManufacturing LLC's 5-category general-payment breakdown at $97.2K, 58.0% of the reported total.

ADMA BioManufacturing LLC reports 5 general-payment categories - the top three are Honoraria (58.0%), Travel and Lodging (19.3%), and Consulting Fee (15.8%). The remaining 2 categories make up 7.0% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.

How ADMA BioManufacturing LLC divides its payments

How the reported total splits across payment categories

1. Honoraria$97.2K2. Travel and Lodging$32.3K3. Consulting Fee$26.4K4. Food and Beverage$10.6K5. Education$1.1K
Payment Type Amount Transactions
Honoraria $97.2K 32
Travel and Lodging $32.3K 44
Consulting Fee $26.4K 902
Food and Beverage $10.6K 79
Education $1.1K 1

Recipient Concentration in General Payments

The five largest recipient relationships account for $77,836.53 (46.4%) of $167,654.40 in this company's General Payments records across 513 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for ADMA BioManufacturing LLC

The five named recipients with the highest reported General Payments from this company

Antoine Azar$26.4KDareen Daranee Siri$22.4KBob Geng$11.4KKevin Rosenbach$9.1KElena E Perez$8.6K
  1. 1

    Antoine Azar

    $26,374.50 across 35 reported transactions

  2. 2

    Dareen Daranee Siri

    $22,409.40 across 24 reported transactions

  3. 3

    Bob Geng

    $11,377.84 across 14 reported transactions

  4. 4

    Kevin Rosenbach

    $9,112.04 across 19 reported transactions

  5. 5

    Elena E Perez

    $8,562.75 across 7 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Spend vs. Concentration

ADMA BioManufacturing LLC ranks #781 of 1,925 by total payments (top 41% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,198 of 1,838 by HHI (bottom 35% least concentrated), a wider distribution than most similarly sized payers.

00.30.50.81.1640.3644.1648651.9655.7Total payments ($M)Concentration (HHI, 0-10,000)
ADMA BioManufacturing LLC (highlighted) among its 12 nearest HHI-concentration neighbors, Program Year 2024. Dashed lines mark this neighborhood's median payment total and median HHI. Hover a point for the company name. Source: company_concentration (CMS Open Payments general-payment recipients).
View all 12 companies in this HHI neighborhood as a list

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as ADMA BioManufacturing LLC's, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about ADMA BioManufacturing LLC.

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with ADMA BioManufacturing LLC.

Showing 6 of 1,924 companies with CMS-reported payment data.

Put this to use

ADMA BioManufacturing LLC ranks #781 of 1,925 by all-tracks total payments, led by "Honoraria".

Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

View saved (companies)
Download ADMA BioManufacturing LLC's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.